Sub-lethal activity of small molecules from natural sources and their synthetic derivatives against biofilm forming Nosocomial pathogens

Current Topics in Medicinal Chemistry

Volumn 13, Issue 24, 2013, Pages 3184-3204

  Villa, Federica ^a   Villa, Stefania ^a   Gelain, Arianna ^a   Cappitelli, Francesca ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Biofilm based infections; Computer aided drug design; Natural compounds; Sub lethal concentrations

Indexed keywords

10 HYDROXY 2 DECENOIC ACID; ASCORBYL GAMOLENATE; AURANTIIN; BAICALEIN; CHLOROGENIC ACID; CHLORZOXAZONE; CHRYSOPHANIC ACID; ELLAGIC ACID; EMODIN; EPIGALLOCATECHIN GALLATE; ESCULETIN; FISETIN; FURANONE DERIVATIVE; HOMOVANILLIC ACID; INDOLE DERIVATIVE; LEAD; MANGIFERIN; MORIN; NATURAL PRODUCT; NIFUROXAZIDE; NODAKENETIN; PATULIN; PLANT EXTRACT; QUINAZOLINE DERIVATIVE; ROSMARINIC ACID; SALICYLIC ACID; SHIKONIN; TANNIN; THYMOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACINETOBACTER BAUMANNII; ANALYTICAL RESEARCH; BIOFILM; BIOLOGICAL ACTIVITY; CANDIDA ALBICANS; CHEMICAL STRUCTURE; COMPUTER AIDED DESIGN; COMPUTER MODEL; DRUG SCREENING; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PATHOGENESIS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA TYPHIMURIUM; SCIENTIFIC LITERATURE; SERRATIA MARCESCENS; STAPHYLOCOCCUS; STENOTROPHOMONAS MALTOPHILIA; SUB LETHAL ACTIVITY; VIBRIO CHOLERAE;

ANTI-BACTERIAL AGENTS; AQUATIC ORGANISMS; BACTERIA; BIOFILMS; BIOLOGICAL PRODUCTS; COMPUTER SIMULATION; CROSS INFECTION; DRUG DESIGN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PLANT EXTRACTS; SMALL MOLECULE LIBRARIES;

EID: 84890895434     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113136660225     Document Type: Review

References (102)

1. Sievert, D.M.; Ricks, P.; Edwards, J.R.; Schneider, A.; Patel, J.; Srinivasan, A.; Kallen, A.; Limbago, B.; Fridkin, S. National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009-2010. Infect. Control. Hosp. Epidemilol. 2013, 34(1), 1-14.
2. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare- associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2013.
3. Singh, P.K.; Schaefer, A.L.; Parsek, M.R.; Moninger, T.O.; Welsh, M.J.; Greenberg, E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature, 2000, 407(6805), 762-764.
4. Fux, C.A.; Costerton, J.W.; Stewart, P.S.; Stoodley, P. Survival strategies of infectious biofilms. Trends Microbiol., 2005, 13(1), 34-40.
5. Vejborg, R.M.; Hancock, V.; Schembri, M.A.; Klemm, P. Comparative genomics of Escherichia coli strains causing urinary tract infections. Appl. Environ. Microbiol., 2011, 77(10), 3268-3278.
6. Brossard, K.A.; Campagnari, A.A. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect. Immun., 2012, 80(1), 228-233.
7. Zijnge, V.; van Leeuwen, M.B.; Degener, J.E.; Abbas, F., Thurnheer, T.; Gmür, R.; Harmsen, H.J. Oral biofilm architecture on natural teeth. PLoS One, 2010, 5(2), e9321.
8. Pang, J.M.; Layre, E.; Sweet, L.; Sherrid, A.; Moody, D.B.; Ojha, A.; Sherman, D.R. The polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosis. J. Bacteriol., 2012, 194(3), 715-721.
9. Shirtliff, M.; Leid, J.G. The Role of Biofilms in Device-Related Infections. Springer, 2010.
10. Smith, K.; Hunter, I.S. Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates. J. Med. Micro-biol., 2008, 57, 966-973.
11. Romero, R.; Schaudinn, C.; Kusanovic, J.P.; Gorur, A.; Gotsch, F.; Webster, P.; Nhan-Chang, C.L.; Erez, O.; Kim, C.J.; Espinoza, J.; Gonçalves, L.F.; Vaisbuch, E.; Mazaki-Tovi, S.; Hassan, S.S.; Cos- terton, J.W. Detection of a microbial biofilm in intraamniotic infection. Am. J. Obstet. Gynecol., 2008, 198(1), 135.e1-5.
12. Bransfield, R.C.; Wulfman, J.S.; Harvey, W.T.; Usman, A.I. The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders. Med. Hypotheses, 2008, 70(5), 967-974.
13. Sapi, E.; Bastian, S.L.; Mpoy, C.M.; Scott, S.; Rattelle, A.; Pabbati, N.; Poruri, A.; Burugu, D.; Theophilus, P.A.; Pham, T.V.; Datar, A.; Dhaliwal, N.K.; MacDonald, A.; Rossi, M.J.; Sinha, S.K.; Luecke, D.F. Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS One, 2012, 7(10), e48277.
14. Costerton, J.W.; Stewart, P.S.; Greenberg, E.P. Bacterial biofilms: a common cause of persistent infections. Science, 1999, 284(5418), 1318-1322.
15. Hall-Stoodley, L.; Costerton, J.W.; Stoodley, P. Bacterial biofilms: from the Natural environment to infectious diseases. Nat. Rev. Mi-crobiol., 2004, 2(2), 95-108.
16. Pace, J.L.; Mark, E., Rupp; Roger G., Finch Boca Raton, FL: Biofilms, Infection, and Antimicrobial Therapy. 2006. CRC Press, Taylor & Francis Group, 2006.
17. Lewis, K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol., 2007, 5(1), 48-56.
18. Flemming, H.C.; Wingender, J. The biofilm matrix. Nat. Rev. Mi-crobiol., 2010, 8(9), 623-633.
19. Kint, C.I.; Verstraeten, N.; Fauvart, M.; Michiels, J. New-found fundamentals of bacterial persistence. Trends Microbiol., 2012, 20(12), 577-585.
20. Høiby, N.; Bjarnsholt, T.; Givskov, M.; Molin, S.; Ciofu, O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents, 2010, 35, 322-332.
21. Kim, S.M.; Kim, H.C.; Lee, S.W. Characterization of antibiotic resistance determinants in oral biofilms. J. Microbiol., 2011, 49(4), 595-602.
22. Bonhomme, J.; D'Enfert, C. Candida albicans biofilms: building a heterogeneous, drug-tolerant environment. Curr. Opin. Microbiol., 2013, In Press, Corrected Proof.
23. Wenzel, M.; Patra, M.; Albrecht, D.; Chen, D.Y.; Nicolaou, K.C.; Metzler-Nolte, N.; Bandow, J.E. Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies. Antimicrob. Agents Chemother., 2011, 55(6), 2590-2596.
24. Blount, K.F.; Wang, J.X.; Lim, J.; Sudarsan, N.; Breaker, R.R. Antibacterial lysine analogs that target lysine riboswitches. Nature Chem. Biol., 2007, 3, 44-49.
25. Rasko, D.A.; Sperandio, V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov., 2010, 9(2), 117-128.
26. Villa, F.; Cappitelli, F. Plant-derived bioactive compounds at sub-lethal concentrations: towards smart biocide-free antibiofilm strategies. Phytochem. Rev., 2013, 12(1), 245-254.
27. Cegelski, L.; Marshall, G.R.; Eldridge, G.R.; Hultgren, S.J. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol., 2008, 6(1), 17-27.
28. Stoodley, P.; Purevdorj-Gage, B.; Costerton, J.W. Clinical significance of seeding dispersal in biofilms: a response. Microbiology, 2005, 151(11), 3453.
29. McDougald, D.; Rice, S.A.; Barraud, N.; Steinberg, P.D.; Kjelle-berg, S. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat. Rev. Microbiol., 2011, 10(1), 39-50.
30. Yim, G.; Wang, H.H.; Davies, J. Antibiotics as signalling molecules. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2007, 362, 1195-1200.
31. Davies, J.; Ryan, K.S. Introducing the parvome: bioactive compounds in the microbial world. ACS Chem. Biol., 2012, 7, 252-259.
32. Ren, D.; Zuo, R.; Gonzalez, A.F.; Bedzyk, L.A.; Eldridge, G.R.; Pasmore, M.E.; Wood, T.K. Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract urso-lic acid. Appl. Environ. Microbiol., 2005, 71, 4022-4034.
33. Hu, J.F.; Garo, E.; Goering, M.G.; Pasmore, M.; Yoo, H.D.; Esser, T.; Sestrich, J.; Cremin, P.C.; Hough, G.W.; Perrone, P.; Lee, Y.; Le, N.; O'Neil-Johnson, M.; Costerton, J.W.; Eldridge, G.R. Bacterial Biofilm Inhibitors from Diospyros dendo. J. Nat. Prod., 2006, 69, 118-120.
34. Junker, L.M.; Clardy, J. High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. Antimicrob. Agents Chemother., 2007, 51(10), 3582-3590.
35. Chopra, I.; Roberts, M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev., 2001 65(2), 232-360.
36. Banin, E.; Brady, K.M.; Greenberg, E.P. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl. Environ. Microbiol., 2006, 72(3) 2064-2069.
37. Rasmussen, L.; White, E.L.; Pathak, A.; Ayala, J.C.; Wang, H.; Wu, J.H.; Benitez, J.A.; Silva, A.J. A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae. Antimicrob. Agents Chemother., 2011, 55(9), 4134-4143.
38. Peach, K.C.; Bray, W.M.; Shikuma, N.J.; Gassner, N.C.; Lokey, R.S.; Yildiz, F.H.; Linington, R.G. An image-based 384-well high-throughput screening method for the discovery of biofilm inhibitors in Vibrio cholerae. Mol. Biosyst., 2011, 7(4), 1176-1184.
39. Robijns, S.C.; De Pauw, B.; Loosen, B.; Marchand, A.; Chaltin, P.; De Keersmaecker, S.C.; Vanderleyden, J.; Steenackers, H.P. Identification and characterization of 4-[4-(3-phenyl-2-propen-1-yl)-1-piperazinyl]-5H-pyrimido[5,4-b]indole derivatives as Salmonella biofilm inhibitors. FEMS Immunol. Med. Microbiol., 2012, 65(2), 390-394.
40. Panmanee, W.; Taylor, D.; Shea, C.J.; Tang, H.; Nelson, S.; Seibel, W.; Papoian, R.; Kramer, R.; Hassett, D.J.; Lamkin, T.J. High-Throughput Screening for Small-Molecule Inhibitors of Staphylo-coccus epidermidis RP62a Biofilms. J. Biomol. Screen, 2013, ahead of print.
41. Villa, F.; Pitts, B.; Stewart, P.S.; Giussani, B.; Roncoroni, S.; Al-banese, D.; Giordano, C.; Tunesi, M.; Cappitelli, F. Efficiancy of zo-steric acid sodium salt on the yeast biofilm model Candida albi-cans. Microb. Ecol., 2011, 62, 584-598.
42. Villa, F.; Borgonovo, G.; Cappitelli, F.; Giussani, B.; Bassoli, A. Sub-lethal concentrations of Muscari comosum bulb extract suppress adhesion and induce detachment of sessile yeast cells. Bio-fouling, 2012, 28, 1107-1117.
43. Olsson, IM.; Johansson, E.; Berntsson, M.; Eriksson, L.; Gottfries, J.; Wold, S. Rational DOE protocols for 96-well plates. Chemometr. Intell. Lab., 2006, 83(1), 66-74.
44. Zeng, Z.; Li, Q.; Lixiang, C; Hongming, T.; Yali, H.; Xiaoli, X.; Yong, S.; Shining, Z. Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol., 2008, 79, 119-126.
45. Yang, L.; Rybtke, M.T.; Jakobsen, T.H.; Hentzer, M.; Bjarnsholt, T.; Givskov, M.; Nielsen, T. Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors. Antimicrob. Agents Chemother., 2009, 53, 2432-2443.
46. Dürig, A.; Kouskoumvekaki, I.; Vejborg, R.M.; Klemm, P. Chemoinformatics-assisted development of new anti-biofilm compounds. Appl. Microbiol. Biotechnol., 2010, 87(1), 309-317.
47. Ding, X.; Yin, B.; Qian, L.; Zeng, Z.; Yang, Z.; Li, H.; Lu, Y.; Zhou, S. Screening for novel quorum-sensing inhibitors to interfere with the formation of Pseudomonas aeruginosa biofilm. J. Med. Microbiol. 2011, 60(12), 1827-1834.
48. Annapoorani, A.; Umamageswaran, V.; Parameswari, R.; Pandian, SK.; Ravi, AV. Computational discovery of putative quorum sensing inhibitors against LasR and RhlR receptor proteins of Pseudomonas aeruginosa. J. Comput. Aided Mol. Des., 2012, 26(9), 1067-1077.
49. De Nys, R.; Steinberg, P.D. Linking marine biology and biotechnology. Curr. Opin. Biotechnol., 2002,13(3), 244-248.
50. Khan, R.; Adil M.; Danishuddin, M.; Verma, P.K.; Khan, A.U. In vitro and in vivo inhibition of Streptococcus mutans biofilm by Trachyspermum ammi seeds: An approach of alternative medicine. Phytomedicine, 2012,19, 747-755.
51. Xu, X.; Zhou, X.D.; Wu, CD. Tea catechin epigallocatechin gallate inhibits Streptococcus mutans biofilm formation by suppressing gtf genes. Arch. Oral Biol., 2012, 57, 678-683.
52. Al-Sohaibani, S.; Murugan, K. Anti-biofilm activity of Salvadora persica on cariogenic isolates of Streptococcus mutans: in vitro and molecular docking studies, Biofouling, 2012, 28(1), 29-38.
53. Stauder, M.; Papetti, A.; Daglia, M.; Vezzulli, L.; Gazzani, G.; Varaldo, P.E.; Pruzzo, C. Inhibitory activity by barley coffee components towards Streptococcus mutans biofilm. Curr. Microbiol., 2010, 61, 417-421.
54. Abraham, S.V.P.I.; Palani, A.; Ramaswamy, B.R.; Shunmugiah, K.P.; Arumugam, V.R. Antiquorum sensing and antibiofilm potential of Capparis Spinosa. Arch. Med. Res., 2011, 42, 658-668.
55. Zahin, M.; Hasan, S.; Aqil, F.; Khan, M.S.A.; Husain, F.M.; Ahmad I. Screening of certain medicinal plants from India for their anti-quorum sensing activity. Indian J. Exp. Biol., 2010, 48, 1219-1224.
56. Kuzma, L.; Wysokinskaa, H.; Rózalski, M.; Budzynska, A.; Wickowska-Szakiel, M.; Sadowska, B.; Paszkiewicz, M.; Kisiel, W.; Rózalska, B. Antimicrobial and anti-biofilm properties of new taxodione derivative from hairy roots of Salvia austriaca. Phytomedicine, 2012,19, 1285-1287.
57. Chursi, S.; Phatthalung, P.N.; Voravuthikunchai, S.P. Anti-biofilm activity of Quercus infectoria G. Olivier against methicillin-resistant Staphiloccoccus aureus. Lett. Appl. Microbiol, 2012, 54, 511-517.
58. Manefield, L.; Welch, M.; Givskov, M.; Salmond, G.P.; Kjeller-Berg, S. Halogenated furanones from the red alga, Delisea pulchra, inhibit carbapenem antibiotic synthesis and exoenzyme virulence factor production in the phytopathogen Erwinia carotovora. FEMS Microbiol. Lett., 2001, 205(1), 131-138.
59. Ren, D.; Sims, J.J.; Wood, T.K. Inhibition of biofilm formation and swarming of Bacillus subtilis by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Lett. Appl. Microbiol., 2002, 34, 293-299.
60. Manefield, M.; Rasmussen, T.B.; Henzter, M.; Andersen, J.B.; Steinberg, P.; Kjellerberg, S.; Givskov, M. Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover. Micro-biol-Sgm, 2002,148(4), 1119-1127.
61. Ren, D.C.; Sims, J.J.; Wood, T.K. Inhibition of biofilm formation and swarming of Escherichia coli by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Environ. Microbiol., 2001, 3(11), 731-756.
62. Hentzer, M.; Wu, H.; Andersen, J. B.; Riedel, K.; Rasmussen, T.B.; Bagge, N.; Kumar, N.; Schembri, M.A.; Song, Z.J.; Kristoffersen, P.; Manefield, M.; Costerton, J.W.; Molin, S.; Eberl, L.; Steinberg, P.; Kjelleberg, S.; Hoiby, N.; Givskov, M. Attenuation of Pseudo-monas aeruginosa virulence by quorum sensing inhibitors. EMBO J., 2003, 22(15) 3803-3815.
63. Hentzer, M.; Riedel, K.; Rasmussen, T. B.; Heydorn, A.; Andersen, J.B.; Parsek, M.R.; Rice, S. A.; Eberl, L.; Molin, S.; Hoiby, N.; Kjelleberg, S.; Givskov, M. Inhibition of quorum sensing in Pseu-domonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiol-Sgm, 2002, 148(1), 87-102.
64. Lonn-Stensrud, J.; Petersen, F.C.; Benneche, T.; Aamdal, S.A. Synthetic bromated furanone inhibits autoinducer-2-mediated communication and biofilm formation in oral streptococci. Oral Microbiol. Immunol., 2007, 22(5), 340-346.
65. Kuehl, R.; Al-Bataineh, S.; Gordon, O.; Luginbuehl, R.; Otto, M.; Textor, M.; Landmann, R. Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxs repression. Antimicrob. Agents Chemother., 2009, 53(10), 4159-4166.
66. Han, H.; Hou, S.; Simon, K.A.; Ren, D.; Luk, Y.Y. Identifying the important structural elements of brominated furanones for inhibiting biofilm formation by Escherichia coli. Bioorg. Med. Chem. Lett. 2008, 18(3), 1006-1010.
67. Kim, C.; Kim, J.; Park, H.Y.; Lee, J.H.; Kim, K.C.; Yoon, J. Fura-none derivatives as quorum-sensing antagonists of Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol., 2008, 80(1), 37-47.
68. Liu, G.Y.; Guo, B.Q.; Chen, W.N.; Cheng, C.; Zhang, Q.L.; Dai, M.B.; Sun, J.R.; Sun, P.H.; Chen, W.M. Synthesis, molecular docking, and biofilm formation inhibitory activity of 5-substituted 3,4-dihalo-5H-furan-2-one derivatives on Pseudomonas aeruginosa. Chem. Biol. Drug Des., 2012, 79, 628-638.
69. Chanas, B.; Pawlik, J.R.; Lindel, T.; Fenical, W. Chemical defense of the Caribbean sponge Agelas clathrodes (Schmidt). J. Exp. Mar. Biol. Ecol., 1997, 208, 185-196.
70. Huigens, R.W.; Richards, J.J.; Parise, G.; Ballard, T.E.; Zeng, W.; Deora, R.; Melander, C. Inhibition of Pseudomonas aeruginosa biofilm formation with bromoageliferin analogues. J. Am. Chem. Soc., 2007, 129, 6966-6967.
71. Huigens, R.W.; Ma, L.Y.; Gambino, C.; Moeller, P.D.; Basso, A.; Cavanagh, J.; Wozniak, D.; Melander, C. Control of bacterial biofilms with marine alkaloid derivatives. Mol. BioSyst., 2008, 4, 614-621.
72. Richards, J.J.; Ballard, T.E.; Huigens, R.W.; Melander, C. Synthesis and screening of an oroidin library against Pseudomonas aeru-ginosa biofilms. Chem. Bio. Chem., 2008, 9(8), 1267-1279.
73. Richards, J.J.; Huigens, R.W.; Ballard, T.E.; Basso, A.; Cavanagh, J.; Melander, C. Inhibition and dispersion of proteobacterial biofilms. Chem. Comm., 2008, 14, 1698-1700.
74. Richards, J.J.; Reed, C.S.; Melander, C. Effects of N-pyrrole substitution on the anti-biofilm activities of oroidin derivatives against Acinetobacter baumannii. Bioorg. Med. Chem. Lett., 2008, 18(15), 4325-4327.
75. Ballard, T.E.; Richards, J.J.; Wolfe, A.L.; Melander, C. Synthesis and antibiofilm activity of a second-generation reverse-amide or-oidin library: a structure-activity relationship study. Chem.-Eur. J. 2008, 14, 10745-10761.
76. Peng, L.; DeSousa, J.; Su, Z.; Novak, B. M.; Nevzorov, N.N.; Garland, E.; Melander, C. Inhibition of Acinetobacter baumannii biofilm formation on a methacrylate polymer containing a 2-aminoimidazole subunit. Chem. Comm., 2011, 47(17), 4896-4898.
77. Rogers, S.A.; Melander, C. Construction and screening of a 2-aminoimidazole library identifies a small molecule capable of inhibiting and dispersing bacterial biofilms across order, class, and phylum. Angew. Chem. Int. Ed., 2008, 47, 5229-5231.
78. Rogers, S.A.; Huigens, R.W.; Cavanagh, J.; Melander, C. Synergis-tic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob. Agents Chemother., 2010, 54, 2112-2118.
79. Reyes, S.; Huigens, R. W.; Su, Z.; Simon, M. L.; Melander, C. Synthesis and biological activity of 2-aminoimidazole triazoles accessed by Suzuki-Miyaura cross-coupling. Org. Biomol. Chem., 2011, 9(8), 3041-3049.
80. Su, Z.; Peng, L.; Worthington, R.J.; Melander, C. Evaluation of 4,5-disubstituted-2-aminoimidazole-triazole conjugates for anti-biofilm/antibiotic resensitization activity against MRSA and Acine-tobacter baumannii. Chem. Med. Chem., 2011, 6(12), 2243-2251.
81. Rogers, S.A.; Bero, J.D.; Melander, C. Chemical Synthesis and biological screening of 2-aminoimidazole-based bacterial and fungal antibiofilm agents. Chem. Bio. Chem., 2010, 11(3), 396-410.
82. Reed, C.S.; Huigens, R.W.; Rogers, S.A.; Melander, C. Modulating the development of E. coli biofilms with 2-aminoimidazoles. Bioorg. Med. Chem. Lett., 2010, 20(21), 6310-6312.
83. Bunders, C; Richards, J.J.; Melander, C. Identification of aryl 2-aminoimidazoles as biofilm inhibitors in Gram-negative bacteria. Bioorg. Med. Chem. Lett., 2010, 20(12), 3797-3800.
84. Steenackers, H.P.L.; Ermolat'Ev, D.S.; Savaliya, B.; De Weerdt, A.; De Coster, D.; Shah, A.; Van Der Eycken, E.V.; De Vos, D.E.; Vanderleyden, J.; De Keersmaecker, S.C.J. Structure-activity relationship of 4(5)-aryl-2-amino-1H-imidazoles, N1-substituted 2-aminoimidazoles and imidazo[1,2-α]pyrimidinium salts as inhibitors of biofilm formation by Salmonella Typhimurium and Pseu-domonas aeruginosa. J. Med. Chem., 2011, 54(2), 472-484.
85. Steenackers, H.P.L.; Ermolat'Ev, D.S.; Savaliya, B.; De Weerdt, A.; De Coster, D.; Shah, A.; Van Der Eycken, E.V.; De Vos, D.E.; Vanderleyden, J.; De Keersmaecker, S.C.J. Structure-activity relationship of 2-hydroxy-2-aryl-2,3-dihydro-imidazo[1,2-a]pyrimidi-nium salts and 2N-substituted 4(5)-aryl-2-amino-1H-imidazoles as inhibitors of biofilm formation by Salmonella Typhimurium and Pseudomonas aeruginosa. Bioorg. Med. Chem., 2011, 19(11), 3462-3473.
86. Ermolat'Ev, D.S.; Bariwal, J.B.; Steenackers, H.P.L.; De Keersmaecker, S.C.J.; Van Der Eycken, E.V. Concise and diversity-oriented route toward polysubstituted 2-aminoimidazole alkaloids and their analogues. Angew. Chem. Int. Ed., 2010, 49, 9465-9468.
87. Rogers, S.A.; Huigens, R.W.; Melander, C. A 2-aminobenzi-midazole that inhibits and disperses gram-positive biofilms through a zinc-dependent mechanism. J. Am. Chem. Soc, 2009, 131, 9868-9869.
88. Lindsey, E.A.; Worthington, R.J.; Alcaraz, C; Melander, C. 2-Aminopyrimidine as a novel scaffold for biofilm modulation. Org. Biomol. Chem., 2012, 10(13), 2552-2561.
89. Appenzeller, J.; Mihci, G.; Martin, M.T.; Gallard, J.F.; Menou, J.L.; Boury-Esnault, N.; Hooper, J.; Petek, S.; Chevalley, S.; Valentin, A.; Zaparucha, A.; Al-Mourabit, A.; Debitus, C. Agelasines J, K, and L from the Solomon Islands Marine Sponge Agelas cf. mauritiana. J. Nat. Prod., 2008, 71(8), 1451-1454.
90. Hertiani, T.; Edrada-Ebel, R.; Ortlepp, S.; van Soest, R. W. M.; de Voogd, N. J.; Wray, V.; Hentschel, U.; Kozytska, S.; Muller, W.E.G.; Proksch, P. From anti-fouling to biofilm inhibition: New cytotoxic secondary metabolites from two Indonesian Agelas sponges. Bioorg. Med. Chem. 2010, 18(3), 1297-1311.
91. Sall, C; Dombrowsky, L.; Bottzeck, O.; Praud-Tabaries, A.; Blache, Y. Targeting bacterial biofilms: design of a terpenoid-like library as non-toxic anti-biofilm compounds. Bioorg. Med. Chem. Lett., 2011, 21, 1493-1497.
92. Carle, J.S.; Christophersen C. Bromo-substituted physostigmine alkaloids from a marine bryozoa Flustra foliacea. J. Am. Chem. Soc, 1979, 101(14), 4012-4013.
93. Carle, J.S.; Christophersen C. Marine alkaloids. 3. Bromo-substituted alkaloids from the marine bryozoan Flustra foliacea, flustramine C and flustraminol A and B. J. Org. Chem., 1981, 46(17), 3440-3443.
94. Lee, J.H.; Lee J. Indole as an intercellular signal in microbial communities. FEMS Microbiol. Rev., 2010, 34(4), 426-444.
95. Lee J.T.; Jayaraman, A; Wood, T.K. Indole is an inter-species biofilm signal mediated by SdiA. BMC Microbiol., 2007, 7, 42.
96. Lindel, T.; Brauchle, L.; Golz, G.; Bohrer, P. Total Synthesis of Flustranime C via Dimethylallyl Rearrangment. Org. Lett., 2007, 9(2), 283-286.
97. Bunders, C; Minvielle, M.J.; Worthington, R.J.; Ortiz, M.; Cavanagh, J.; Melander, C. Intercepting bacterial indole signaling with flustramine derivatives. J. Am. Chem. Soc, 2011, 133(50), 20160-20163.
98. Bunders, C; Cavanagh, J.; Melander, C. Flustramine inspired synyhesis and biological evaluation of pyrroloindoline triazole amides as novel inhibitors of bacterial biofilms. Org. Biomol. Chem. 2011, 9(15), 5476-5481.
99. Rogers, S.A.; Whitehead, D.C.; Mullikin, T; Melander, C. Synthesis and bacterial biofilm inhibition studies of ethyl N-(2-phenethyl) carbamate derivatives. Org. Biomol. Chem., 2010, 8, 3857-3859.
100. Melander, C.; Rogers S.A. Inhibition of bacterial biofilms with aryl carbamates. Patent WO2012006276, July 12, 2012.
101. Bottcher, T.; Kolodkin-Gal, I.; Kolter, R.; Losick, R.; Clardy, J. Synthesis and Activity of Biomimetic Biofilm disruptors. J. Am. Chem. Soc., 2013, 135(8), 2927-2930.
102. Davies, D.G.; Marques, C.N.H. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol., 2009, 191(5), 1393-1403.